The Board of Directors of Regel Therapeutics, a gene regulation company, announced that Stephen J. Farr, PhD, begins as Chief Executive Officer (CEO).
Dr. Farr served...
Firefly Neuroscience, Inc., a pioneering artificial intelligence (“AI”) driven company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological...
Small molecule drug discovery acceleration experts and DNA-encoded library (DEL) technology pioneers X-Chem, Inc. welcomes Paul Davie as Chief Business Officer. He will lead global business development,...
Exostar, a leader in trusted, secure business collaboration solutions for highly regulated industries including aerospace and defense, life sciences, and healthcare, announced Derrick Reig has joined the company...
